China News Service, Nanning, April 30 (Kong Guojun, Lin Hao) Guangxi Market Supervision Bureau Party Secretary He Zhaojian said on the 30th that Guangxi will help enterprises improve product quality, through testing and certification and other means to open up the export supply chain and promote "Guizhou" The export of anti-epidemic products and the establishment of an internationally renowned brand of "Made in Gui".
Since the outbreak of the new crown epidemic, Guangxi has escorted the development of the pharmaceutical industry throughout the entire journey. The supply structure of medical supplies has shifted from purchasing and donation to independent production, completing the fundamental transformation from passive "blood transfusion" to active "blood production".
At present, the global demand for anti-epidemic supplies is increasing, and Guangxi medical material production enterprises are increasing the pace of product export.
Peili (Nanning) Pharmaceutical Co., Ltd. is one of the six national trial production enterprises of traditional Chinese medicine formula granules approved by the State Food and Drug Administration, and its products are exported to the United States, Singapore, Hong Kong, Macau and other countries and regions. Zhou Jian, director of the company's production management department and deputy director of the Pharmaceutical Research Institute, introduced that after the occurrence of the new coronary pneumonia epidemic, the Guangxi Food and Drug Administration emergency passed the three formula granule products of "Qingfei Detox Decoction", "Kangfu No. 1 Granule" and "Qiweitang Granule". For the record, the company donated the products to the Guangxi aid-Episodesis medical team and the front-line medical personnel, isolation personnel and patients in the recovery period of Hubei Province for use. At present, the company's Angusheng raw materials and Hawthorn and Astragalus formula particles have passed the USP certification of the United States Pharmacopoeia Commission, the particle production line has passed the Australian TGA certification, and the products are being sold to Australia and some EU countries.
In February this year, Guangxi Juxing Medical Devices Co., Ltd. urgently built a civilian mask and medical mask production project, and with the help of the Guangxi market supervision and drug supervision department, it obtained the disposable medical mask (non- Sterile) medical device registration certificate. At present, the company has 2 production lines officially produced, with a daily output of 100,000 masks.
Liao Changxiang, head of Guangxi Juxing Medical Devices Co., Ltd., said that after the outbreak of the new coronary pneumonia, Guangxi market supervision and drug regulatory departments opened green approval channels in a timely manner, started emergency approval procedures, and took the initiative to visit the service. The company ’s flat masks received CE and FDA (LYU) Certification, the rapid growth of corporate mask sales. At the end of May, there will be two additional production lines for medical flat masks and five medical protective masks (KN95). By then, the output of these two masks will reach 6 million pieces / month and 5 million pieces / month, respectively. Next, we will improve the quality of products sold overseas and strive to expand sales.
He Zhaojian said that with the global spread of the new coronary pneumonia epidemic, countries around the world are in urgent need of anti-epidemic supplies. Guangxi will scientifically coordinate and promote the protection of anti-epidemic supplies, continue to support services to support enterprises to resume production and production; strengthen technical support, continue to promote inspection and testing capabilities, focus Emergency approval of the supervision of listed medical devices, to prevent unqualified products from flowing into the market, and to ensure the safety and effectiveness of public medical devices.
He Zhaojian also said that while the Guangxi market supervision and drug regulatory departments are making every effort to guarantee the quality and safety of epidemic prevention products, they will also investigate the situation of enterprises producing masks, protective clothing and other epidemic prevention products in their jurisdictions through various channels, and whether they have obtained export certification and certification. Types, certification models, certification standards, certification agencies and other information should be mastered in detail, and relevant information should be combed and analyzed to help qualified enterprises obtain international certification as soon as possible, providing a powerful tool for "Gui Gui" anti-epidemic products to enter the international market. Technical support and services have accelerated the promotion of the "Made in Gui" artificial intelligence and epidemic prevention products to overseas sales, driving the overall leap and leapfrog development of Guangxi's competitiveness. (Finish)